Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

Similar articles for PubMed (Select 19298631)

1.

Lithium restores neurogenesis in the subventricular zone of the Ts65Dn mouse, a model for Down syndrome.

Bianchi P, Ciani E, Contestabile A, Guidi S, Bartesaghi R.

Brain Pathol. 2010 Jan;20(1):106-18. doi: 10.1111/j.1750-3639.2008.00246.x. Epub 2009 Mar 3.

PMID:
19298631
2.

Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with Down syndrome and in Ts65Dn mice.

Contestabile A, Fila T, Ceccarelli C, Bonasoni P, Bonapace L, Santini D, Bartesaghi R, Ciani E.

Hippocampus. 2007;17(8):665-78.

PMID:
17546680
3.

Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for Down syndrome.

Bianchi P, Ciani E, Guidi S, Trazzi S, Felice D, Grossi G, Fernandez M, Giuliani A, Calzà L, Bartesaghi R.

J Neurosci. 2010 Jun 30;30(26):8769-79. doi: 10.1523/JNEUROSCI.0534-10.2010.

4.

Age-related impairment of olfactory bulb neurogenesis in the Ts65Dn mouse model of Down syndrome.

Bianchi P, Bettini S, Guidi S, Ciani E, Trazzi S, Stagni F, Ragazzi E, Franceschini V, Bartesaghi R.

Exp Neurol. 2014 Jan;251:1-11. doi: 10.1016/j.expneurol.2013.10.018. Epub 2013 Nov 2.

PMID:
24192151
5.

Fluoxetine rescues deficient neurogenesis in hippocampus of the Ts65Dn mouse model for Down syndrome.

Clark S, Schwalbe J, Stasko MR, Yarowsky PJ, Costa AC.

Exp Neurol. 2006 Jul;200(1):256-61. Epub 2006 Apr 19.

PMID:
16624293
6.

Cell cycle elongation impairs proliferation of cerebellar granule cell precursors in the Ts65Dn mouse, an animal model for Down syndrome.

Contestabile A, Fila T, Bartesaghi R, Ciani E.

Brain Pathol. 2009 Apr;19(2):224-37. doi: 10.1111/j.1750-3639.2008.00168.x. Epub 2008 May 14.

PMID:
18482164
7.

Early-occurring proliferation defects in peripheral tissues of the Ts65Dn mouse model of Down syndrome are associated with patched1 over expression.

Fuchs C, Ciani E, Guidi S, Trazzi S, Bartesaghi R.

Lab Invest. 2012 Nov;92(11):1648-60. doi: 10.1038/labinvest.2012.117. Epub 2012 Aug 13.

8.

Effects of voluntary physical exercise on adult hippocampal neurogenesis and behavior of Ts65Dn mice, a model of Down syndrome.

Llorens-Martín MV, Rueda N, Tejeda GS, Flórez J, Trejo JL, Martínez-Cué C.

Neuroscience. 2010 Dec 29;171(4):1228-40. doi: 10.1016/j.neuroscience.2010.09.043. Epub 2010 Sep 26.

PMID:
20875841
9.

Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model.

Guidi S, Stagni F, Bianchi P, Ciani E, Giacomini A, De Franceschi M, Moldrich R, Kurniawan N, Mardon K, Giuliani A, Calzà L, Bartesaghi R.

Brain. 2014 Feb;137(Pt 2):380-401. doi: 10.1093/brain/awt340. Epub 2013 Dec 12.

10.

Enlarged brain ventricles and impaired neurogenesis in the Ts1Cje and Ts2Cje mouse models of Down syndrome.

Ishihara K, Amano K, Takaki E, Shimohata A, Sago H, Epstein CJ, Yamakawa K.

Cereb Cortex. 2010 May;20(5):1131-43. doi: 10.1093/cercor/bhp176. Epub 2009 Aug 26.

11.

Widespread impairment of cell proliferation in the neonate Ts65Dn mouse, a model for Down syndrome.

Contestabile A, Fila T, Cappellini A, Bartesaghi R, Ciani E.

Cell Prolif. 2009 Apr;42(2):171-81. doi: 10.1111/j.1365-2184.2009.00587.x.

PMID:
19317805
12.

Neurogenesis and aging: FGF-2 and HB-EGF restore neurogenesis in hippocampus and subventricular zone of aged mice.

Jin K, Sun Y, Xie L, Batteur S, Mao XO, Smelick C, Logvinova A, Greenberg DA.

Aging Cell. 2003 Jun;2(3):175-83.

PMID:
12882410
13.

Early pharmacotherapy with fluoxetine rescues dendritic pathology in the Ts65Dn mouse model of down syndrome.

Guidi S, Stagni F, Bianchi P, Ciani E, Ragazzi E, Trazzi S, Grossi G, Mangano C, Calzà L, Bartesaghi R.

Brain Pathol. 2013 Mar;23(2):129-43. doi: 10.1111/j.1750-3639.2012.00624.x. Epub 2012 Sep 3.

PMID:
22817700
14.
15.

Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse.

Baxter LL, Moran TH, Richtsmeier JT, Troncoso J, Reeves RH.

Hum Mol Genet. 2000 Jan 22;9(2):195-202.

16.

Environmental enrichment rescues postnatal neurogenesis defect in the male and female Ts65Dn mouse model of Down syndrome.

Chakrabarti L, Scafidi J, Gallo V, Haydar TF.

Dev Neurosci. 2011;33(5):428-41. doi: 10.1159/000329423. Epub 2011 Aug 25.

17.

Cell proliferation is reduced in the dentate gyrus of aged but not young Ts65Dn mice, a model of Down syndrome.

Rueda N, Mostany R, Pazos A, Flórez J, Martínez-Cué C.

Neurosci Lett. 2005 May 20-27;380(1-2):197-201. Epub 2005 Feb 5.

PMID:
15854777
18.

APP-dependent up-regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndrome.

Trazzi S, Mitrugno VM, Valli E, Fuchs C, Rizzi S, Guidi S, Perini G, Bartesaghi R, Ciani E.

Hum Mol Genet. 2011 Apr 15;20(8):1560-73. doi: 10.1093/hmg/ddr033. Epub 2011 Jan 25.

19.

Reduced hippocampal neurogenesis and number of hilar neurones in streptozotocin-induced diabetic mice: reversion by antidepressant treatment.

Beauquis J, Roig P, Homo-Delarche F, De Nicola A, Saravia F.

Eur J Neurosci. 2006 Mar;23(6):1539-46.

PMID:
16553617
20.

Neurogenesis impairment and increased cell death reduce total neuron number in the hippocampal region of fetuses with Down syndrome.

Guidi S, Bonasoni P, Ceccarelli C, Santini D, Gualtieri F, Ciani E, Bartesaghi R.

Brain Pathol. 2008 Apr;18(2):180-97. Epub 2007 Dec 17.

PMID:
18093248
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk